DAIC

JUNE 25, 2024

Food and Drug Administration ( FDA ) clearance and commercial launch of KAI 12L AI technology and the Kardia 12L ECG System. The Kardia 12L ECG System, featuring a game-changing patented technology, is the world’s first AI-powered handheld 12-lead electrocardiogram ( ECG ) system with a unique single-cable design.

Technology 116

Technology Heart Attack Heart attacks Innovation 116

DAIC

JANUARY 3, 2024

milla1cf Wed, 01/03/2024 - 12:09 January 3, 2024 — iRhythm Technologies, Inc. , The Zio monitor ECG System secured its CE mark based on compliance to EU MDR standards of performance, quality, safety, and efficacy, along with the body of clinical evidence supporting Zio in detecting potential cardiac arrhythmias. Data on file.

Technology 98

Technology Certification Arrhythmia Electrocardiogram 98

DAIC

JUNE 11, 2024

Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. When left untreated, arrhythmias may significantly increase the risk of stroke , heart failure , and sudden cardiac arrest.

Heart Rhythm 81

Heart Rhythm Technology Electrophysiology Arrhythmia 81

Circulation

FEBRUARY 13, 2025

The coronary care unit gradually evolved from a focus on rapid resuscitation from ventricular arrhythmias in acute myocardial infarction into a comprehensive cardiac intensive care unit designed to care for the sickest patients with cardiovascular disease.

Critical Care 72

Critical Care Myocardial Infarction Research Cardiovascular Disease 72

HeartRhythm

JULY 21, 2024

The global health challenge posed by cardiac arrhythmias, particularly atrial fibrillation (AF), is significant, with heightened risks of stroke, heart failure, and systemic embolism1. Traditional arrhythmia detection has often missed transient or asymptomatic episodes, relying on symptomatic presentations and episodic monitoring.

Technology 45

Technology Arrhythmia Atrial Fibrillation Heart Failure 45

DAIC

JULY 16, 2024

mtaschetta-millane Tue, 07/16/2024 - 09:47 July 16, 2024 — Ultrahuman, a pioneer in wearable technology , launches PowerPlugs, a platform for individual apps and plugins built on top of Ultrahuman’s health and wellness data stack. AFib is the most common type of irregular heart rhythm or arrhythmia.

AFIB 105

AFIB Technology Heart Rhythm Arrhythmia 105

Cardiomatics

APRIL 5, 2024

In a world where technology reigns supreme, one of the most profound tools in medicine remains the irreplaceable electrocardiogram (ECG). As technology advances, so too does our ability to capture the heart’s rhythm with greater precision. 1] Arrhythmia Recognition: The Art of Interpretation, T.Garcia, D.Garcia.

Arrhythmia 92

Arrhythmia Tachycardia Bradycardia Electrocardiogram 92

DAIC

MAY 10, 2024

milla1cf Fri, 05/10/2024 - 08:17 May 10, 2024 — With cardiovascular disease being a leading cause of mortality worldwide, Vivalink , a leading provider of digital healthcare solutions, announces the launch of its comprehensive technology solution designed for Mobile Cardiac Telemetry (MCT) and Holter monitoring.

Technology 105

Technology Arrhythmia Heart Rhythm Cardiovascular Disease 105

Cardiomatics

FEBRUARY 5, 2025

A key focus of the research was heart rate variability (HRV)analyzed using our AI-powered ECG technology. Whether you study HRV, arrhythmias, long-term ECG monitoring, or metabolic health, our platform can help. These commonly used anti-inflammatory drugs often cause insulin resistance, high cholesterol, and muscle loss.

Research 93

Research Hospital Diabetes Electrophysiology 93

MIBHS

JANUARY 31, 2025

In the age of technology, wearable devices have revolutionized how we approach health and wellness. This blog explores the ways wearable technology can help track heart health, the advantages it offers, and how it contributes to better outcomes for those requiring surgical intervention.

Heart Rhythm 52

Heart Rhythm Technology AFIB Exercise 52

DAIC

FEBRUARY 14, 2025

Despite advances in catheter ablation technology, persistent AF remains one of the most challenging subtypes of atrial fibrillation to treat, affecting over 70% of all patients with atrial fibrillation globally. tim.hodson Fri, 02/14/2025 - 09:57 Feb. These patients represent a more advanced AF disease progression. adult population.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Technology Pulmonary 52

DAIC

JULY 11, 2024

The first implant follows the full market release of BIOTRONIK’s newest family of pacemaker and CRT-P devices, featuring patient-centric technologies for better patient care and simplified workflows. Enhanced Closed Loop Stimulation (CLS) rate adaptation technology. Streamlined Care Pathways.

Pacemaker 105

Pacemaker Allied Health Technology Arrhythmia 105

DAIC

FEBRUARY 12, 2024

milla1cf Mon, 02/12/2024 - 15:18 February 12, 2024 — BIOTRONIK , a leader in implantable medical device technology, announced today they will solely supply their proprietary DX models for new single-chamber ICD implants moving forward. Hindricks G, et al. Eur Heart J. 2021 Feb 1;42(5):373-498. Biffi M, Iori M, De Maria E, et al.

Technology 64

Technology Atrial Fibrillation Defibrillator Sudden Cardiac Death 64

HeartRhythm

JULY 29, 2024

With the introduction of, and improvements in, fetal cardiac diagnostic technologies, we inch ever closer to the reality of fetal cardiac intensive care.

Technology 40

Technology Article Arrhythmia 40

DAIC

APRIL 8, 2025

FDA Breakthrough Medical Device Designation Prior to this FDA clearance, ViaOne had already received and was taking part in the FDAs prestigious Breakthrough Device Designation (BDD) program, recognizing its potential to deliver more effective treatments for patients with complex cardiac arrhythmias.

Electrophysiology 52

Electrophysiology Arrhythmia Innovation Technology 52

DAIC

JUNE 11, 2024

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

HeartRhythm

AUGUST 31, 2024

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Smart technologies such as smartphones and smartwatches used in everyday life offer promising avenues for enhancing AF management.

Atrial Fibrillation 40

Atrial Fibrillation Technology Heart Rhythm Arrhythmia 40

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Volta Medical’s AI solution is designed to assist electrophysiologists in real-time assessment of dispersed electrograms (EGMs).

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

HeartRhythm

AUGUST 31, 2024

The role of wearable technology in detecting AF in cardio-oncology has not been well defined. Patients with CLL are at increased risk of developing atrial fibrillation (AF), however AF is a known side effect of ibrutinib therapy as well and is associated with worse outcomes.

Cardio Oncology 40

Cardio Oncology Technology Atrial Fibrillation Arrhythmia 40

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9 million in Europe by 2060.

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

Journal of Cardiovascular Electrophysiology

JANUARY 31, 2024

Bipolar catheter ablation for highly refractory cardiac arrhythmia—does rate of success depend on arrhythmia origin? Abstract Introduction Despite rapid technological progress, some arrhythmias are still resistant to standard unipolar ablation.

Arrhythmia 40

Arrhythmia Ablation Technology Article 40

HeartRhythm

APRIL 30, 2024

The characterization of cardiac arrhythmias with standard clinically equipment presents challenges in diagnosis and treatment. Some high-resolution technologies such as optical mapping can help to apply new techniques to improve the currently commercial systems.

Arrhythmia 40

Arrhythmia Technology 40

DAIC

JULY 10, 2024

Following are a few characteristics that distinguish the next evolution of the cardiology practice: Enthusiastic use of technology: The cardiology clinic of the future overcomes fear of adoption and embraces technology as a force multiplier for operational efficiency and clinical outcomes. And these technologies are already available.

Technology 106

Technology Best Practices AFIB Patient Care 106

HeartRhythm

APRIL 30, 2024

TARLess is a novel technology that enables LAT mapping in absence of any TAR offers promising step toward atrial fibrillation activation mapping. Moreover, TARLess is unaffected by unintended shifts and drifts in the reference catheter, saving substantial time otherwise needed to regenerate maps of regular arrhythmias after such shifts.

Arrhythmia 40

Arrhythmia Atrial Fibrillation Technology 40

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105

DAIC

MARCH 26, 2024

The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Food and Drug Administration (FDA) in July 2023, a new leadless pacemaker system placed in both chambers of the heart and using a novel communication technology is now offering a more minimally invasive option for patients.

Pacemaker 105

Pacemaker Heart Rhythm Arrhythmia Atrial Fibrillation 105

MIBHS

FEBRUARY 28, 2025

Arrhythmias: Genetic mutations can also predispose individuals to irregular heart rhythms, such as atrial fibrillation or long QT syndrome, which may increase the risk of stroke or sudden cardiac arrest. Gene Editing: Technologies like CRISPR can potentially correct harmful genetic mutations, although this remains largely experimental.

Genetic predisposition 52

Genetic predisposition Heart Disease Cholesterol Blood Pressure 52

DAIC

JULY 30, 2024

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology.

Heart Rhythm 105

Heart Rhythm Innovation Technology Education 105

Journal of Cardiovascular Electrophysiology

MARCH 4, 2024

ECG data during the clinical arrhythmia (ventricular tachycardia [VT], upper left figure) is analyzed with an artificial intelligence algorithm which identifies a probable location of the source of the arrhythmia (left ventricular anterolateral papillary muscle, lower left figure). cm, LVEF 50 ± 18%) and was similar to 28 controls.

Arrhythmia 40

Arrhythmia Ablation Tachycardia Atrial Fibrillation 40

Heart BMJ

FEBRUARY 12, 2024

The National Institute for Health and Care Excellence (NICE) guidelines present a synopsis of extensive internal evidence and technology reviews, with a particular focus on clinical efficacy and cost-effectiveness within the NHS in England.

Arrhythmia 40

Arrhythmia Sudden Cardiac Death Atrial Fibrillation Heart Rhythm 40

HeartRhythm

APRIL 30, 2024

Atrial conduction abnormalities are common among patients with congenital heart disease, predisposing them to arrhythmias. In clinical practice, substrates are usually identified during electrophysiological mapping procedures using bipolar electrograms (EGM).

Congenital Heart Disease 40

Congenital Heart Disease Technology Electrophysiology Congenital 40

DAIC

DECEMBER 29, 2023

Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

DAIC

MAY 18, 2024

Atrial fibrillation is the most common type of arrhythmia, and by 2050, up to 16 million Americans are projected to have AF 1. Recent technological advancements, such as catheter design and energy delivery, can pave the way for the wider adoption of PFA in clinical practice to improve patient outcomes.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

Frontiers in Cardiovascular Medicine

DECEMBER 19, 2023

Background The rising adoption of wearable technology increases the potential to identify arrhythmias. Those with arrhythmias or non-diagnostic EKGs were sent 7-day monitors. The EHR was reviewed after 3 years to determine if participants developed arrhythmias. Mean age was 50.5 (SD years, and 46 (53.3%) were female.

Blood Pressure 64

Blood Pressure Atrial Fibrillation AFIB Arrhythmia 64

DAIC

MAY 21, 2024

Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

Heart Rhythm 52

Heart Rhythm Innovation Electrophysiology Technology 52

HeartRhythm

AUGUST 31, 2024

Wearable technologies are being used by patients for ECG rate and rhythm monitoring. To date, it has not been possible to incorporate the collected data into clinical practice.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Technology 40

HeartRhythm

DECEMBER 15, 2024

The technology features a proprietary 3-dimensional electroanatomic mapping system. A novel focal lattice-tip catheter allowing the delivery of either pulsed field (PF) or radiofrequency (RF) energy has recently received regulatory approval.

Arrhythmia 40

Arrhythmia Technology Ablation 40